Transgenomic, Inc. (TBIO.OB) Receives Grant of $1,070,453 from U.S. Government
Located in Omaha, Nebraska, Transgenomic has earned a reputation as a global biotechnology company specializing in high sensitivity genetic variation and mutation analysis. Today, Transgenomic announced they have received a $1,070,453 grant from the U.S. Government. The award was granted under the Patent Protection and Affordable Care Act and is among the larger awards that any one company has received under the act. Four of the young company’s Research and Development (R & D) programs received the highest maximum allowable award of $244,479.25 each. Under the Act, $1 billion was earmarked for qualifying therapeutic discovery projects that treat areas of…